期刊文献+

^99Tc^m-DMP444肺动脉血栓与下肢深静脉血栓显像的实验研究 被引量:4

Detection of experimental pulmonary thrombosis and deep venous thrombosis by ^99Tc^m-DMP444
原文传递
导出
摘要 目的探讨小分子多肽血栓显像剂^99Tc^m-邻苯二甲酸二甲酯(DMP)444在PE和下肢深静脉血栓(DVT)动物模型中的显像效果。方法选5条杂种犬,制备左下肺动脉血栓和右股静脉血栓动物模型。注射显像剂后即刻(30s)、2、3、4、5、10、15、30、60、90和120min分别取静脉血1ml,测质量及放射性计数。以注射后即刻的血液放射性计数为100%,计算各时间点的^99Tc^m-DMP444血液清除率。注射后15、30、60、90和120min,分别进行胸部及双后肢平面显像。应用ROI方法,分别计算肺血栓/肺本底(P/L)、股静脉血栓/对侧股静脉血(D/B)和股静脉血栓/肌肉本底(D/M)的放射性比值。显像结束后,取出血栓分别测定肺动脉血栓和股静脉血栓摄取^99Tc^mDMP444的%ID/g。不同时间点均数之间的差异采用单向重复测量方差分析。结果^99Tc^m-DMP444注射后120min的血液清除率为(65.4±3.9)%。左下肺动脉及右股静脉血栓部位放射性摄取随时间逐步增强,注射后15至120min,P/L,D/B和D/M比值分别从2.41±0.28、1.67±0.33、2.20±0.14增加至3.96±0.64、2.56±0.57、3.90±0.95,差异均有统计学意义(F=14.57、7.68和9.37,P均〈0.05)。PE和后肢DVT的%ID/g分别为0.085±0.023和0.054±0.018。结论^99Tc^m-DMP444能无创性地早期检测急性PE和下肢DVT,是较为理想的小分子多肽血栓显像剂。 Objective To evaluate ^99Tc^m-dimethyl pathalate (DMP)444 scintigraphy for detection of PE and deep venous thrombosis (DVT) in animal models. Methods The experimental PE and DVT were induced in 5 dogs. Venous blood samples ( 1 ml ) were collected at 30 s, 2 min, 3 min, 4 min, 5 rain, 10 min, 15 min, 30 rain, 60 rain, 90 min and 120 rain respectively after the tracer injection. The collected blood samples were weighed and counted for radioactivity in a ,y-counter. The radioactivity was expressed as a percentage of the initial (30 s) activity. The blood clearance rate at each time point was obtained. The im-ages of lungs and legs were acquired at 15, 30, 60, 90 and 120 min alter the injection. ROI was drawn on PE, DVT, lung, contralateral femoral vein and lateral thigh for calculating the radioactivity ratios of PE/ lung (P/L), DVT/blood (D/B) and DVT/muscle (D/M). PE and DVT were removed, weighed and counted for radioactivity ex vivo to determine the % ID/g. Data at different time points were compared by one-way repeated measures analysis of variance. Results Blood clearance rate of^99Tc^m-DMPd44 was (65.4±3.9 ) % at 120 min after the injection. The radioactivity ratios of PE and DVT increased over time, and the radioactivity ratios of P/L, D/B and D/M increased from 2.41 ±0.28, 1.67± 0.33, 2.20± 0.14 at 15 min to 5.96±0. 64, 2.56±0.57, 3.90±0.95 at 120 min, after the injection respectively ( F = 14. 57,7.68,9.37, all P 〈 0.05). The % ID/g of PE and DVT was 0.085 ± 0. 023 and 0. 054 ± 0.018 respectively. Conclusion ^99Tc^m-DMP444 may become a potential radiopharmaceutical agent for noninvasively detecting PE and DVT.
出处 《中华核医学与分子影像杂志》 CSCD 北大核心 2012年第1期59-62,共4页 Chinese Journal of Nuclear Medicine and Molecular Imaging
基金 北京市科技计划(Y0204004040731)
关键词 血栓形成 肺动脉 股静脉 放射性核素显像 DMP444 Thrombosis Pulmonary artery Femoral vein Radionuclide imaging DMP444 Dogs
  • 相关文献

参考文献15

  • 1Dalen JE. Pulmonary embolism: what have we learned since Vir- chow? Natural history, pathophysiology, and diagnosis. Chest, 2002, 122: 1440-1456.
  • 2Gleeson FV, Turner S, Scarsbrook AF. Improving the diagnostic performance of lung scintigraphy in suspected pulmonary embolic disease. Clin Redid, 2006, 61: 1010-1015.
  • 3Hull RD, Carter CJ, Jay RM, et al. The diagnosis of acute, recur- rent, deep-vein thrombosis : a diagnostic challenge. Circulation,1983, 67: 901-906.
  • 4Barrett JA, Crocker AC, Damphousse DJ, et al. Biological evalua- tion of thrombus imaging agents utilizing water soluble phosphines and tricine as coligands when used to label a hydrazinonicoti- namide-modified cyclic glycoprotein Ⅱb/Ⅲ a receptor antagonist with 99Tcm. Bioconjug Chem, 1997, 8: 155-160.
  • 5Oyen WJ, Boerman OC, Brouwers FM, et al. Scintigraphic detec- tion of acute experimental endocarditis with the Tcm labelled gly- coprotein Ⅱ b/Ⅲ a receptor antagonist DMP444. Eur J Nucl Med, 2000, 27 : 392-399.
  • 6Lister-James J, Knight LC, Maurer AH, et al. Thrombus imaging with a 99Tcm-labeled activated platelet receptor-binding peptide. J Nucl Med, 1996, 37: 775-781.
  • 7方纬,季顺东,刘秀杰,阮长耿,王峰,史蓉芳,王琦.肺动脉血栓放射免疫显像实验研究[J].中华核医学杂志,2002,22(3):188-190. 被引量:6
  • 8季顺东,方纬,范磊,董宁征,刘秀杰,阮长耿,何作祥.^(99)Tc^m标记人源化抗人血小板膜糖蛋白Ⅲa单克隆抗体SZ21F(ab)_2血栓栓塞显像[J].中华核医学杂志,2007,27(3):173-176. 被引量:4
  • 9吴锦昌,沈利明,陆之安,阮长耿.^(99)Tc^m-抗人活化血小板单抗SZ-51对犬冠状动脉血栓的放免显像研究[J].中华核医学杂志,2000,20(5):197-198. 被引量:4
  • 10Stratton JR, Dewhurst TA, Kasina S, et al. Selective uptake of radio- labeled annexln V on acute porcine left atrial thrombi. Circulation, 1995, 92: 3113-3121.

二级参考文献26

共引文献11

同被引文献22

  • 1李晓强,王深明.深静脉血栓形成的诊断和治疗指南(第2版)[J].中国医学前沿杂志(电子版),2013,5(3):53-57. 被引量:127
  • 2吴锦昌,何广仁,阮长耿.^(99m)Tc抗人活化血小板单克隆抗体SZ-51对狗动、静脉血栓的放免显像研究[J].中华核医学杂志,1994,14(1):35-37. 被引量:8
  • 3张鹏,施海彬,刘圣,李麟荪.犬下肢深静脉血栓模型的实验研究[J].介入放射学杂志,2006,15(5):299-302. 被引量:4
  • 4季顺东,方纬,范磊,董宁征,刘秀杰,阮长耿,何作祥.^(99)Tc^m标记人源化抗人血小板膜糖蛋白Ⅲa单克隆抗体SZ21F(ab)_2血栓栓塞显像[J].中华核医学杂志,2007,27(3):173-176. 被引量:4
  • 5Heit JA, Cohen AT, Anderson FA. Estimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE) events in the US. ASH Annual Meeting, 2005, 106(11): 910.
  • 6Vriens PW, Blankenberg FG, Stoot JH, et al. The use of technetium Tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejection. J Thorac Cardiovasc Surg, 1998, 116(5): 844-853.
  • 7Johnson LL, Schofield L, Donahay T, et al. 99mTc-annexin V imaging for in vivo detection of atherosclerotic lesions in porcine coronary arteries. J Nucl Med, 2005, 46(7): 1186-1193.
  • 8Zhu L, Liu BL, Guo YZ. 99Tcm direct labeling of Annexin V for potential apoptosis imaging in vivo. J Labelled Comp Rad, 2003, (z I): S324.
  • 9Torbicki A, Van Beek ER, Charbonnier B, et al. Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology. Eur Heart J, 2000, 21 (16): 1301-1336.
  • 10Fang W, He J, Kim YS, et al. Evaluation of 99mTc-labeled cyclic RGD peptide with a PEG4 linker for thrombosis imaging: comparison with DMP444. Bioconjug Chern, 2011, 22(8): 17 I 5- I 722.

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部